NO973421L - Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA - Google Patents
Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNAInfo
- Publication number
- NO973421L NO973421L NO973421A NO973421A NO973421L NO 973421 L NO973421 L NO 973421L NO 973421 A NO973421 A NO 973421A NO 973421 A NO973421 A NO 973421A NO 973421 L NO973421 L NO 973421L
- Authority
- NO
- Norway
- Prior art keywords
- dna
- recombinant dna
- heavy chain
- recombinant
- myosin heavy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4716—Muscle proteins, e.g. myosin, actin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1008595 | 1995-01-25 | ||
| PCT/JP1996/000134 WO1996023069A1 (en) | 1995-01-25 | 1996-01-25 | Recombinant dna prepared by integrating dna that codes for myosin heavy-chain sm1 isoform protein into vector dna, and microorganism and arteriosclerosis remedy both containing the recombinant dna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO973421D0 NO973421D0 (no) | 1997-07-24 |
| NO973421L true NO973421L (no) | 1997-09-22 |
Family
ID=11740510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973421A NO973421L (no) | 1995-01-25 | 1997-07-24 | Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6593304B1 (de) |
| EP (1) | EP0806477B1 (de) |
| JP (1) | JP3092944B2 (de) |
| KR (1) | KR19980701695A (de) |
| AT (1) | ATE236977T1 (de) |
| AU (1) | AU711757B2 (de) |
| CA (1) | CA2211468A1 (de) |
| DE (1) | DE69627307T2 (de) |
| FI (1) | FI973104A7 (de) |
| HU (1) | HUP9801762A1 (de) |
| NO (1) | NO973421L (de) |
| NZ (1) | NZ300270A (de) |
| WO (1) | WO1996023069A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11285333A (ja) * | 1998-02-05 | 1999-10-19 | Vessel Research Laboratory:Kk | 変異型平滑筋ミオシン重鎖遺伝子を有する非ヒト動物の胚幹細胞および非ヒト動物 |
| CN1321672A (zh) * | 2000-04-29 | 2001-11-14 | 上海博德基因开发有限公司 | 一种新的多肽——人肌球蛋白重链12－14和编码这种多肽的多核苷酸 |
| US6974688B2 (en) * | 2001-08-10 | 2005-12-13 | Cytokinetics, Inc. | Human smooth muscle myosin heavy chain |
| US10590452B2 (en) | 2017-12-20 | 2020-03-17 | University Of Seoul Industry Cooperation Foundation | DNA-Mn hybrid particles and method of manufacturing the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0646841A (ja) | 1992-07-24 | 1994-02-22 | Kyowa Hakko Kogyo Co Ltd | トランスフェリン非要求性細胞 |
-
1996
- 1996-01-25 KR KR1019970705091A patent/KR19980701695A/ko not_active Ceased
- 1996-01-25 FI FI973104A patent/FI973104A7/fi unknown
- 1996-01-25 JP JP08522776A patent/JP3092944B2/ja not_active Expired - Lifetime
- 1996-01-25 WO PCT/JP1996/000134 patent/WO1996023069A1/ja not_active Ceased
- 1996-01-25 US US08/875,435 patent/US6593304B1/en not_active Expired - Fee Related
- 1996-01-25 AT AT96901112T patent/ATE236977T1/de not_active IP Right Cessation
- 1996-01-25 HU HU9801762A patent/HUP9801762A1/hu unknown
- 1996-01-25 CA CA002211468A patent/CA2211468A1/en not_active Abandoned
- 1996-01-25 DE DE69627307T patent/DE69627307T2/de not_active Expired - Fee Related
- 1996-01-25 EP EP96901112A patent/EP0806477B1/de not_active Expired - Lifetime
- 1996-01-25 NZ NZ300270A patent/NZ300270A/en unknown
- 1996-01-25 AU AU44961/96A patent/AU711757B2/en not_active Ceased
-
1997
- 1997-07-24 NO NO973421A patent/NO973421L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU4496196A (en) | 1996-08-14 |
| WO1996023069A1 (en) | 1996-08-01 |
| EP0806477B1 (de) | 2003-04-09 |
| EP0806477A4 (de) | 2000-01-05 |
| EP0806477A1 (de) | 1997-11-12 |
| DE69627307T2 (de) | 2004-03-04 |
| FI973104L (fi) | 1997-09-24 |
| HUP9801762A1 (hu) | 1998-11-30 |
| DE69627307D1 (de) | 2003-05-15 |
| AU711757B2 (en) | 1999-10-21 |
| NZ300270A (en) | 1998-09-24 |
| ATE236977T1 (de) | 2003-04-15 |
| JP3092944B2 (ja) | 2000-09-25 |
| KR19980701695A (ko) | 1998-06-25 |
| NO973421D0 (no) | 1997-07-24 |
| US6593304B1 (en) | 2003-07-15 |
| FI973104A0 (fi) | 1997-07-24 |
| FI973104A7 (fi) | 1997-09-24 |
| CA2211468A1 (en) | 1996-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69434447D1 (de) | Für die gentherapie verwendbare plasmide | |
| NO981353L (no) | Regulerte gener og anvendelser derav | |
| TR199802676A2 (xx) | T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem. | |
| NO974824L (no) | Arteriovenöse og venöse transplantasjonsbehandlinger, fremgangsmåter og blandinger | |
| HUP9902867A3 (en) | Therapeutic use of vegf protein or nucleic acid coding same and implant, especially for the treatment of intimal hyperplasia | |
| AU2002311777A1 (en) | Method of treating arthritis using lentiviral vectors in gene therapy | |
| NO910982D0 (no) | Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. | |
| AU2001258316A1 (en) | Process for the fermentative preparation of l-threonine | |
| AU2225199A (en) | Human suppressor trna oligonucleotides and methods of use for same | |
| FI961666A7 (fi) | Restenosiksen geeniterapia, jossa käytetään adenovirusvektoria | |
| DK0687184T3 (da) | Rekombinante adenoviruser og anvendelse deraf ved genterapi til behandling af øjensygdomme | |
| DE69721824D1 (de) | Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen | |
| NO973421L (no) | Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA | |
| EP0707655A1 (de) | Dna-expressionsvektoren zur verwendung in der gentherapeutischen behandlung von gefässerkrankungen | |
| AU4037299A (en) | Genetically-modified fibroblasts and the use thereof | |
| DE69733948D1 (de) | In vivo herstellung von replicativen molekülen | |
| ZA949807B (en) | Regulatory nucleic acid sequences and uses | |
| NO985558L (no) | Ny forbedret formulering for behandling av tromboembolisme | |
| ATE271878T1 (de) | Verwendung von protein h als zytostattischer wirkstoff | |
| AU2002252443A1 (en) | Method of treating arthritis using lentiviral vectors in gene therapy | |
| NZ505580A (en) | Method of treating immunodeficiences using neutrokine alpha | |
| ATE309354T1 (de) | Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen | |
| PT1133297E (pt) | Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina | |
| GB2333527A (en) | Therapeutic gene |